Complications of Androgen-Deprivation Therapy for Prostate Cancer

Jeffrey M. Holzbeierlein, Erik P Castle, J. Brantley Thrasher

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

With the increasing indications for the use of androgen-deprivation therapy in the treatment of men with prostate cancer, side effects of the therapy deserve greater attention. Side effects such as hot flashes, decreased libido, decreased sexual function, and fatigue primarily affect the patient's quality of life. Other side effects such as osteoporosis and changes in lipid profiles may also affect the patient's overall health. Treatments such as estrogen, megestrol acetate, antidepressants, and bisphosphonates are useful in the management of many of the deleterious side effects of androgen deprivation. In addition, alternative management strategies such as intermittent androgen ablation and antiandrogen monotherapy may be useful in minimizing side effects caused by androgen ablation. Patients and physicians should be well aware of the potential side effects of androgen-deprivation therapy as well as the preventive and treatment strategies for these side effects in order to improve patients' quality of life and health.

Original languageEnglish (US)
Pages (from-to)147-152
Number of pages6
JournalClinical Prostate Cancer
Volume2
Issue number3
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Androgens
Prostatic Neoplasms
Therapeutics
Quality of Life
Megestrol Acetate
Hot Flashes
Androgen Antagonists
Libido
Health
Diphosphonates
Antidepressive Agents
Osteoporosis
Fatigue
Estrogens
Physicians
Lipids

Keywords

  • Hot flashes
  • Hypogonadism
  • Luteinizing hormone-releasing hormone agonists
  • Osteoporosis
  • Testosterone

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Complications of Androgen-Deprivation Therapy for Prostate Cancer. / Holzbeierlein, Jeffrey M.; Castle, Erik P; Thrasher, J. Brantley.

In: Clinical Prostate Cancer, Vol. 2, No. 3, 12.2003, p. 147-152.

Research output: Contribution to journalArticle

Holzbeierlein, JM, Castle, EP & Thrasher, JB 2003, 'Complications of Androgen-Deprivation Therapy for Prostate Cancer', Clinical Prostate Cancer, vol. 2, no. 3, pp. 147-152.
Holzbeierlein, Jeffrey M. ; Castle, Erik P ; Thrasher, J. Brantley. / Complications of Androgen-Deprivation Therapy for Prostate Cancer. In: Clinical Prostate Cancer. 2003 ; Vol. 2, No. 3. pp. 147-152.
@article{dcec4453e06249bdaaab2d7b352db804,
title = "Complications of Androgen-Deprivation Therapy for Prostate Cancer",
abstract = "With the increasing indications for the use of androgen-deprivation therapy in the treatment of men with prostate cancer, side effects of the therapy deserve greater attention. Side effects such as hot flashes, decreased libido, decreased sexual function, and fatigue primarily affect the patient's quality of life. Other side effects such as osteoporosis and changes in lipid profiles may also affect the patient's overall health. Treatments such as estrogen, megestrol acetate, antidepressants, and bisphosphonates are useful in the management of many of the deleterious side effects of androgen deprivation. In addition, alternative management strategies such as intermittent androgen ablation and antiandrogen monotherapy may be useful in minimizing side effects caused by androgen ablation. Patients and physicians should be well aware of the potential side effects of androgen-deprivation therapy as well as the preventive and treatment strategies for these side effects in order to improve patients' quality of life and health.",
keywords = "Hot flashes, Hypogonadism, Luteinizing hormone-releasing hormone agonists, Osteoporosis, Testosterone",
author = "Holzbeierlein, {Jeffrey M.} and Castle, {Erik P} and Thrasher, {J. Brantley}",
year = "2003",
month = "12",
language = "English (US)",
volume = "2",
pages = "147--152",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Complications of Androgen-Deprivation Therapy for Prostate Cancer

AU - Holzbeierlein, Jeffrey M.

AU - Castle, Erik P

AU - Thrasher, J. Brantley

PY - 2003/12

Y1 - 2003/12

N2 - With the increasing indications for the use of androgen-deprivation therapy in the treatment of men with prostate cancer, side effects of the therapy deserve greater attention. Side effects such as hot flashes, decreased libido, decreased sexual function, and fatigue primarily affect the patient's quality of life. Other side effects such as osteoporosis and changes in lipid profiles may also affect the patient's overall health. Treatments such as estrogen, megestrol acetate, antidepressants, and bisphosphonates are useful in the management of many of the deleterious side effects of androgen deprivation. In addition, alternative management strategies such as intermittent androgen ablation and antiandrogen monotherapy may be useful in minimizing side effects caused by androgen ablation. Patients and physicians should be well aware of the potential side effects of androgen-deprivation therapy as well as the preventive and treatment strategies for these side effects in order to improve patients' quality of life and health.

AB - With the increasing indications for the use of androgen-deprivation therapy in the treatment of men with prostate cancer, side effects of the therapy deserve greater attention. Side effects such as hot flashes, decreased libido, decreased sexual function, and fatigue primarily affect the patient's quality of life. Other side effects such as osteoporosis and changes in lipid profiles may also affect the patient's overall health. Treatments such as estrogen, megestrol acetate, antidepressants, and bisphosphonates are useful in the management of many of the deleterious side effects of androgen deprivation. In addition, alternative management strategies such as intermittent androgen ablation and antiandrogen monotherapy may be useful in minimizing side effects caused by androgen ablation. Patients and physicians should be well aware of the potential side effects of androgen-deprivation therapy as well as the preventive and treatment strategies for these side effects in order to improve patients' quality of life and health.

KW - Hot flashes

KW - Hypogonadism

KW - Luteinizing hormone-releasing hormone agonists

KW - Osteoporosis

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0346964515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346964515&partnerID=8YFLogxK

M3 - Article

C2 - 15040857

AN - SCOPUS:0346964515

VL - 2

SP - 147

EP - 152

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 3

ER -